Natural killer cells in chronic lyme disease

Clinical and Vaccine Immunology

Volumn 16, Issue 11, 2009, Pages 1704-

  Stricker, Raphael B ^a   Winger, Edward E ^b  

^a International Lyme and Associated Diseases Society   (United States)

^b Alan E Beer Center for Reproductive Immunology and Genetics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CD3 ANTIGEN; CD57 ANTIGEN;

ANTIBIOTIC THERAPY; CELL COUNT; CHRONIC DISEASE; FLOW CYTOMETRY; LETTER; LYME DISEASE; NATURAL KILLER T CELL; PATIENT SELECTION; PRIORITY JOURNAL; SEROLOGY;

ANIMALS; FEMALE; HUMANS; KILLER CELLS, NATURAL; LYME DISEASE; MALE;

EID: 70350731280     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00260-09     Document Type: Letter

References (5)

1. Jarefors, S., L. Bennet, E. You, P. Forsberg, C. Ekerfelt, J. Berglund, and J. Ernerudh. 2006. Lyme borreliosis reinfection: might it be explained by a gender difference in immune response? Immunology 118:224-232.
2. Marques, A., M. R. Brown, and T. A. Fleisher. 2009. Natural killer cell counts are not different between patients with post-Lyme disease syndrome and controls. Clin. Vaccine Immunol. 16:1249-1250.
3. Stricker, R. B., and E. E. Winger. 2001. Decreased CD57 lymphocyte subset in patients with chronic Lyme disease. Immunol. Lett. 76:43-48.
4. Stricker, R. B., V. R. Savely, N. C. Motanya, and P. C. Giclas. 2009. Complement split products C3a and C4a in chronic Lyme disease. Scand. J. Immunol. 69:64-69.
5. Stricker, R. B., and L. Johnson. 2009. Gender bias in chronic Lyme disease. J. Womens Health 18:1717-1718.